New farnesoid X receptor agonist Px-20606 prevents nonalcoholic steatohepatitis in an animal model April 8, 2011
Liver-selective glucokinase activator PFE-GKA-2 shows improved hypoglycemic control in vivo April 6, 2011
Furiex Pharma evaluates PPD-10558 in phase II study in subjects with statin intolerance April 4, 2011
RSS